Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Express Scripts
Dow
McKinsey
Mallinckrodt

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for PHA-793887

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug PHA-793887?

PHA-793887 is an investigational drug.

There have been 28 clinical trials for PHA-793887. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 1999.

The most common disease conditions in clinical trials are Thymoma, HIV Infections, and Leukemia. The leading clinical trial sponsors are National Cancer Institute (NCI), Nerviano Medical Sciences, and Pfizer.

Recent Clinical Trials for PHA-793887
TitleSponsorPhase
The Benefit of Bermekimab in Patients With Systemic SclerosisHellenic Institute for the Study of SepsisPhase 2
The Effects of Nanocurcumin on Serum miRNA and Th17 Cells Development Factors in Ankylosing Spondylitis PatientsStem Cell and Regenerative Medicine Institute, Tabriz, IranPhase 2
Recurrent Wheezing in Infants: Risk Factors and Prevention With Probiotics.Conselho Nacional de Desenvolvimento Científico e TecnológicoPhase 3

See all PHA-793887 clinical trials

Clinical Trial Summary for PHA-793887

Top disease conditions for PHA-793887
Top clinical trial sponsors for PHA-793887

See all PHA-793887 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Merck
Mallinckrodt
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.